GBI Research

191 products published

GBI Research

191 products published

GBI Research is a leading provider of market information studies based on the healthcare sector. Offering a mix of product pipeline analysis, benchmarking and market digests as well as overall market overviews, GBI Research provide invaluable information for any company operating within the healthcare and pharmaceutical industries. Employing a truly unique method of primary data collection, overseen by their team of experienced researchers, GBI Research are able to provide market-leading solutions that can help your company stay at the very top of the industry.

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Menopausal Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Menopausal Disorders Drug Development Pipeline Review, 2018

  • Report
  • 84 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • 133 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Mosquito-borne Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Mosquito-borne Diseases Drug Development Pipeline Review, 2018

  • Report
  • 142 Pages
From
Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

  • Report
  • 112 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms - Product Thumbnail Image

Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

  • Report
  • 68 Pages
From
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

  • Report
  • 376 Pages
From
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease - Product Thumbnail Image

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

  • Report
  • 77 Pages
From
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies - Product Thumbnail Image

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

  • Report
  • 92 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • 181 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
Fungal Foot Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Fungal Foot Infections Drug Development Pipeline Review, 2018

  • Report
  • 58 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline - Product Thumbnail Image

Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline

  • Report
  • 86 Pages
From
Loading Indicator
adroll